NuShores Biosciences LLC
NuShores Biosciences LLC, founded in 2014, is dedicated to commercializing patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company aims to improve the quality of life for individuals with severe tissue regeneration needs through innovative solutions like the NuCress™ bone scaffold technology, which is designed to promote healing in large segmental bone defects.
Industries
Nr. of Employees
small (1-50)
NuShores Biosciences LLC
1523 South Bowman St. Suite 3-H, Little Rock, Arkansas 72211
Awards
NuCressTM Intelligent Factory in a Box
Funding (ceiling)
$3,251,714
Award Year
2020
Products
Bone void filler polymeric scaffold (pre-market)
A controlled-porosity, hydrophilic polymeric bone scaffold intended to fill large segmental bone defects and support bone regeneration; designed for surgical use in cranio-maxillofacial, dental, limb, and spinal indications. Product is not FDA cleared or available for sale.
Bone void filler polymeric scaffold (pre-market)
A controlled-porosity, hydrophilic polymeric bone scaffold intended to fill large segmental bone defects and support bone regeneration; designed for surgical use in cranio-maxillofacial, dental, limb, and spinal indications. Product is not FDA cleared or available for sale.
Expertise Areas
- Bone and tissue regeneration
- Biomaterials development for implantable scaffolds
- Preclinical animal models and translational research
- Medical device manufacturing and production scale-up
Key Technologies
- Controlled-porosity polymeric scaffolds
- Hydrophilic in situ-swelling implant design
- Bioabsorbable polyurethane polymerization
- DBM (demineralized bone matrix) and hydroxyapatite composite integration
Key People
Featured In Technology Showcase
NuCress™ Factory in a Box Enables Sterile, On-demand Medical Device Production
This type of portable and automated manufacturing unit could be used in various military settings, from field hospitals to naval medical bays, enabling the on-site production of medical devices.
Investors
Arkansas Economic Development Commission
$100,000 funded.
Announced on 2020-01-14.
Grant - NuShores Biosciences
$1,700,000 funded.
Announced on 2018-08-08.
Seed Round - NuShores Biosciences
$100,000 funded.
Announced on 2017-05-01.
Arkansas Economic Development Commission
$100,000 funded.
Announced on 2020-01-14.
Grant - NuShores Biosciences
$1,700,000 funded.
Announced on 2018-08-08.
Seed Round - NuShores Biosciences
$100,000 funded.
Announced on 2017-05-01.
News & Updates
NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC).
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium to support the commercialization of their NuCress™ bone filler scaffolds.
Sam Monk, a seasoned medical device professional, will help to lead NuShores’ quality and regulatory efforts for NuCress™ bone regenerative product line.
NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC).
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium to support the commercialization of their NuCress™ bone filler scaffolds.
Sam Monk, a seasoned medical device professional, will help to lead NuShores’ quality and regulatory efforts for NuCress™ bone regenerative product line.